Prudencio Balagtas, DO
Physical Medicine & Rehabilitation · Cleveland, OHNPI 1366505059
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,290 of the $8,484 with a category attached, or 74.1%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.6%. Reporting peaked in 2022 at $2,902 and has fallen 50.5% since, to $1,437 in 2025. Among physical medicine & rehabilitation clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $39.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertos Medical, Inc.$2K
- Relievant Medsystems, Inc.$1K
- Boston Scientific$1K
- Medtronic$835
- Nevro Corp.$423
- Scilex Pharmaceuticals Inc.$368
- plus $3K from 22 others
What the payments were for
- Consulting fees$1752%
- Travel & lodging$2,01924%
- Food & beverage$6,29074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertos Medical, Inc. | 9 | $1,830 |
| Relievant Medsystems, Inc. | 18 | $1,082 |
| Boston Scientific | 40 | $1,071 |
| Medtronic(2 entities) | 12 | $835 |
| Nevro Corp. | 5 | $423 |
| Scilex Pharmaceuticals Inc. | 25 | $368 |
| SPR Therapeutics, Inc | 4 | $336 |
| Pfizer | 28 | $315 |
| Electronic Waveform Lab, Inc. | 13 | $308 |
| Saluda Medical Americas, Inc. | 4 | $289 |
| Amgen | 3 | $219 |
| MML US, Inc. | 2 | $218 |
| Collegium Pharmaceutical, Inc. | 12 | $203 |
| Merz Pharmaceuticals, LLC | 4 | $124 |
| Assertio Therapeutics, Inc. | 8 | $124 |
| Painteq LLC | 1 | $115 |
| Abbott | 3 | $105 |
| Curonix LLC | 5 | $98 |
| Almatica Pharma LLC | 5 | $96 |
| AbbVie | 3 | $71 |
| Vertex | 3 | $67 |
| Johnson & Johnson(2 entities) | 2 | $57 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Nalu Medical, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Si-bone, Inc. | 1 | $19 |
| Zimmer Biomet | 1 | $15 |
| Misonix Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,679
- mild Device Kit$1,774
- Senza Spinal Cord Stimulation System$370
- INTELLIS ADAPTIVESTIM$297
- INTELLIS$259
- SPRINT PNS System$208
- Prolia$175
- ReActiv8$166
- PAINTEQ$115
- Evoke SCS$110
How this compares
$8,484 in reported general payments places this provider in the 90th percentile of 332 physical medicine & rehabilitation providers in Ohio.
See all physical medicine & rehabilitation providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 12 | $17,836 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $1,647 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $1,074 |
| Gabapentin | 54 | $839 |
| Baclofen | 16 | $375 |
| Ibuprofen | 21 | $263 |
| Methadone Hcl | 12 | $221 |
| Tramadol Hcl | 11 | $72 |
| Meloxicam | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta | $203 | $17,83612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 332 physical medicine & rehabilitation providers in Ohio.
Other physical medicine & rehabilitation in Cleveland
- Francois BethouxCleveland$39K
- Maria GrabnarCleveland$13K
- John ChaeCleveland$10K
- John McCallinCleveland$8K
- Marzena BuzanowskaCleveland$6K
- Tariq NiaziCleveland$2K
- Santhosh ThomasCleveland$2K
- Michael BariaLewis Center$175K
- Kathryn MosherAkron$121K
- Marc OrlandoCincinnati$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.